Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey Lieberman, MD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP
Stephen Marder, MD
Digital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Chia-Chun Chiang, MD
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO
Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
Susan Scanland, MSN, CRNP, GNP-BC, CDP
Anthony J. Viera, MD, MPH
Endogenous Pathways in Migraine Care: Harnessing the Body's Natural Systems
Adriana Della Pietra, MD
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Shelina Ramnarine, PhD
Michelle Scargle, MD
Margaret Emerson, DNP, APRN, PMHNP-BC
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
Hamid Abuwarda, PhD, BS
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
Jeffrey A. Lieberman, MD
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Charles Turck, PharmD, BCPS, BCCCP
David Kimhy, PhD
Harnessing AI to Predict and Prevent Schizophrenia Relapse
Matcheri S. Keshavan, MD
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Caterina Garone, MD, PhD
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
Cristina Domínguez González, MD, PhD
Timing Meningococcal Vaccines in gMG: Challenges and Considerations
Michael Weiss, MD
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.